| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Pathology Division, National Cancer Center Research Institute, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104 [M. I., A. O., S. A., S. H.], Japan, and First Department of Surgery, Oita Medical University, 1-1, Hasama-machi, Oita 879-55 [M. I., S. K.], Japan
It has been found that ß-catenin, a key regulator of the cadherin-mediated cell adhesion system, forms complexes with adenomatous polyposis coli (APC) tumor suppressor protein, and ß-catenin expression levels are affected by exogenously induced APC protein. The effects of intrinsic APC protein alteration on ß-catenin expression levels and its subcellular localization were examined in colonic epithelia of eight patients with familial adenomatous polyposis. In all eight patients, ß-catenin was immunostained at the membranes of the cell-to-cell borders in normal epithelial cells, whereas the nuclei and cytoplasms stained intensely in addition to the membranes in both adenoma and cancer cells. ß-Catenin expression levels in tumor tissues were over three times higher than those in corresponding normal mucosae of all of the three patients, whose resected specimens were available for quantitative immunoblot analysis. In these three patients, mutant truncated APC proteins were detected and shown to have lost the central region, including a known ß-catenin binding domain. ß-Catenin was not coimmunoprecipitated with these mutant APC proteins in tumor tissues but was able to be coprecipitated with glutathione S-transferase-fused APC protein containing a ß-catenin binding domain. These results suggest that the absence of wild-type APC protein affects the subcellular localization and expression levels of ß-catenin in human tissues.
1 This work was supported in part by a Grant-in-Aid for the 2nd Term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health and Welfare of Japan. M.I. is an awardee of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research.
2 To whom requests for reprints should be addressed. Phone: 81-3-3542-2511 (Ext. 4201) Fax: 81-3-3248-2737.
Received 11/ 6/95. Accepted 2/27/96.
This article has been cited by other articles:
![]() |
C. M. Nagamine, J. J. Sohn, B. H. Rickman, A. B. Rogers, J. G. Fox, and D. B. Schauer Helicobacter hepaticus Infection Promotes Colon Tumorigenesis in the BALB/c-Rag2-/- ApcMin/+ Mouse Infect. Immun., June 1, 2008; 76(6): 2758 - 2766. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Baltgalvis, F. G. Berger, M. M. O. Pena, J. M. Davis, and J. A. Carson Effect of exercise on biological pathways in ApcMin/+ mouse intestinal polyps J Appl Physiol, April 1, 2008; 104(4): 1137 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Misikangas, A.-M. Pajari, E. Paivarinta, S. I. Oikarinen, J. Rajakangas, M. Marttinen, H. Tanayama, R. Torronen, and M. Mutanen Three Nordic Berries Inhibit Intestinal Tumorigenesis in Multiple Intestinal Neoplasia/+ Mice by Modulating {beta}-Catenin Signaling in the Tumor and Transcription in the Mucosa J. Nutr., October 1, 2007; 137(10): 2285 - 2290. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. C. Wong, E. S. F. Lo, K. C. Lee, J. K. C. Chan, and W. L. W. Hsiao Prognostic and Diagnostic Significance of {beta}-Catenin Nuclear Immunostaining in Colorectal Cancer Clin. Cancer Res., February 15, 2004; 10(4): 1401 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-F. Chu, R. S. Esworthy, P. G. Chu, J. A. Longmate, M. M. Huycke, S. Wilczynski, and J. H. Doroshow Bacteria-Induced Intestinal Cancer in Mice with Disrupted Gpx1 and Gpx2 Genes Cancer Res., February 1, 2004; 64(3): 962 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
S C C Wong, E S F Lo, A K C Chan, K C Lee, and W L Hsiao Nuclear {beta} catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong Mol. Pathol., December 1, 2003; 56(6): 347 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ghiselli, N. Coffee, C. E. Munnery, R. Koratkar, and L. D. Siracusa The Cohesin SMC3 Is a Target the for {beta}-Catenin/TCF4 Transactivation Pathway J. Biol. Chem., May 23, 2003; 278(22): 20259 - 20267. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nabais, J. C. Machado, C. Lopes, R. Seruca, F. Carneiro, and M. Sobrinho-Simoes Patterns of {beta}-Catenin Expression in Gastric Carcinoma: Clinicopathological Relevance and Mutation Analysis International Journal of Surgical Pathology, January 1, 2003; 11(1): 1 - 9. [Abstract] [PDF] |
||||
![]() |
G. D. Girnun, W. M. Smith, S. Drori, P. Sarraf, E. Mueller, C. Eng, P. Nambiar, D. W. Rosenberg, R. T. Bronson, W. Edelmann, et al. APC-dependent suppression of colon carcinogenesis by PPARgamma PNAS, October 15, 2002; 99(21): 13771 - 13776. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Anderson, K. L. Neufeld, and R. L. White Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon PNAS, June 25, 2002; 99(13): 8683 - 8688. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Albuquerque, M Cravo, C Cruz, P Lage, P Chaves, P Fidalgo, A Suspiro, and C Nobre Leitao Genetic characterisation of patients with multiple colonic polyps J. Med. Genet., April 1, 2002; 39(4): 297 - 302. [Full Text] [PDF] |
||||
![]() |
J. J. Keller, G. J. A. Offerhaus, P. Drillenburg, E. Caspers, A. Musler, A. Ristimaki, and F. M. Giardiello Molecular Analysis of Sulindac-resistant Adenomas in Familial Adenomatous Polyposis Clin. Cancer Res., December 1, 2001; 7(12): 4000 - 4007. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lifschitz-Mercer, R. Amitai, B. B.-S. Maymon, L. Shechtman, B. Czernobilsky, L. Leider-Trejo, A. Ben-Ze'ev, and B. Geiger Nuclear Localization of {beta}-Catenin and Plakoglobin in Primary and Metastatic Human Colonic Carcinomas, Colonic Adenomas, and Normal Colon International Journal of Surgical Pathology, October 1, 2001; 9(4): 273 - 279. [Abstract] [PDF] |
||||
![]() |
L. D. Miller, K. S. Park, Q. M. Guo, N. W. Alkharouf, R. L. Malek, N. H. Lee, E. T. Liu, and S.-y. Cheng Silencing of Wnt Signaling and Activation of Multiple Metabolic Pathways in Response to Thyroid Hormone-Stimulated Cell Proliferation Mol. Cell. Biol., October 1, 2001; 21(19): 6626 - 6639. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Sellin, S. Umar, J. Xiao, and A. P. Morris Increased {beta}-Catenin Expression and Nuclear Translocation Accompany Cellular Hyperproliferation in Vivo Cancer Res., April 1, 2001; 61(7): 2899 - 2906. [Abstract] [Full Text] |
||||
![]() |
S. Groos, E. Reale, and L. Luciano Re-evaluation of Epoxy Resin Sections for Light and Electron Microscopic Immunostaining J. Histochem. Cytochem., March 1, 2001; 49(3): 397 - 406. [Abstract] [Full Text] |
||||
![]() |
Y. Naishiro, T. Yamada, A. S. Takaoka, R. Hayashi, F. Hasegawa, K. Imai, and S. Hirohashi Restoration of Epithelial Cell Polarity in a Colorectal Cancer Cell Line by Suppression of {beta}-catenin/T-Cell Factor 4-mediated Gene Transactivation Cancer Res., March 1, 2001; 61(6): 2751 - 2758. [Abstract] [Full Text] |
||||
![]() |
L. Lo Muzio A Possible Role for the Wnt~1 Pathway in Oral Carcinogenesis Critical Reviews in Oral Biology & Medicine, January 1, 2001; 12(2): 152 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Kishimoto, N Takata, T Jinnai, T Morisawa, G Shiota, H Kawasaki, and J Hasegawa Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane Gut, December 1, 2000; 47(6): 812 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamada, A. S. Takaoka, Y. Naishiro, R. Hayashi, K. Maruyama, C. Maesawa, A. Ochiai, and S. Hirohashi Transactivation of the Multidrug Resistance 1 Gene by T-Cell Factor 4/{beta}-Catenin Complex in Early Colorectal Carcinogenesis Cancer Res., September 1, 2000; 60(17): 4761 - 4766. [Abstract] [Full Text] |
||||
![]() |
F. T. Kolligs, B. Kolligs, K. M. Hajra, G. Hu, M. Tani, K. R. Cho, and E. R. Fearon gamma -Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta -catenin Genes & Dev., June 1, 2000; 14(11): 1319 - 1331. [Abstract] [Full Text] |
||||
![]() |
H. S. Cooper, S. Murthy, K. Kido, H. Yoshitake, and A. Flanigan Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation Carcinogenesis, April 1, 2000; 21(4): 757 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Demetter, D Baeten, F De Keyser, M De Vos, N Van Damme, G Verbruggen, S Vermeulen, M Mareel, D Elewaut, H Mielants, et al. Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex Ann Rheum Dis, March 1, 2000; 59(3): 211 - 216. [Abstract] [Full Text] |
||||
![]() |
F. Sanvito, F. Vivoli, S. Gambini, G. Santambrogio, M. Catena, E. Viale, F. Veglia, A. Donadini, S. Biffo, and P. C. Marchisio Expression of a Highly Conserved Protein, p27BBP, during the Progression of Human Colorectal Cancer Cancer Res., February 1, 2000; 60(3): 510 - 516. [Abstract] [Full Text] |
||||
![]() |
J. T. V. Nhieu, C. A. Renard, Y. Wei, D. Cherqui, E. S. Zafrani, and M. A. Buendia Nuclear Accumulation of Mutated {beta}-Catenin in Hepatocellular Carcinoma Is Associated with Increased Cell Proliferation Am. J. Pathol., September 1, 1999; 155(3): 703 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Orford, C. C. Orford, and S. W. Byers Exogenous Expression of {beta}-Catenin Regulates Contact Inhibition, Anchorage-Independent Growth, Anoikis, and Radiation-Induced Cell Cycle Arrest J. Cell Biol., August 23, 1999; 146(4): 855 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Munné, M. Fabre, M. L. Mariñoso, M. Gallén, F. X. Real, and for the Colon Cancer Team at IMAS Nuclear {beta}-catenin in Colorectal Tumors: To Freeze or Not To Freeze? J. Histochem. Cytochem., August 1, 1999; 47(8): 1089 - 1094. [Abstract] [Full Text] |
||||
![]() |
C. Gamallo, J. Palacios, G. Moreno, J. Calvo de Mora, A. Suarez, and A. Armas {beta}-Catenin Expression Pattern in Stage I and II Ovarian Carcinomas : Relationship with {beta}-Catenin Gene Mutations,Clinicopathological Features, and Clinical Outcome Am. J. Pathol., August 1, 1999; 155(2): 527 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van Hengel, P. Vanhoenacker, K. Staes, and F. van Roy Nuclear localization of the p120ctn Armadillo-like catenin is counteracted by a nuclear export signal and by E-cadherin expression PNAS, July 6, 1999; 96(14): 7980 - 7985. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Engle, J. B. Hoying, G. P. Boivin, I. Ormsby, P. S. Gartside, and T. Doetschman Transforming Growth Factor {beta}1 Suppresses Nonmetastatic Colon Cancer at an Early Stage of Tumorigenesis Cancer Res., July 1, 1999; 59(14): 3379 - 3386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. McEntee, C.-H. Chiu, and J. Whelan Relationship of ß-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice Carcinogenesis, April 1, 1999; 20(4): 635 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Orsulic, O Huber, H Aberle, S Arnold, and R Kemler E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation J. Cell Sci., January 4, 1999; 112(8): 1237 - 1245. [Abstract] [PDF] |
||||
![]() |
S. Hirohashi Inactivation of the E-Cadherin-Mediated Cell Adhesion System in Human Cancers Am. J. Pathol., August 1, 1998; 153(2): 333 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Salomon, P. A. Sacco, S. G. Roy, I. Simcha, K. R. Johnson, M. J. Wheelock, and A. Ben-Ze'ev Regulation of {beta}-Catenin Levels and Localization by Overexpression of Plakoglobin and Inhibition of the Ubiquitin-Proteasome System J. Cell Biol., December 1, 1997; 139(5): 1325 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ilyas, I. P. M. Tomlinson, A. Rowan, M. Pignatelli, and W. F. Bodmer beta -Catenin mutations in cell lines established from human colorectal cancers PNAS, September 16, 1997; 94(19): 10330 - 10334. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Vleminckx, E. Wong, K. Guger, B. Rubinfeld, P. Polakis, and B. M. Gumbiner Adenomatous Polyposis Coli Tumor Suppressor Protein Has Signaling Activity in Xenopus laevis Embryos Resulting in the Induction of an Ectopic Dorsoanterior Axis J. Cell Biol., January 27, 1997; 136(2): 411 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hayashi, B. Rubinfeld, B. Souza, P. Polakis, E. Wieschaus, and A. J. Levine A Drosophila homolog of the tumor suppressor gene adenomatous polyposis coli down-regulates beta -catenin but its zygotic expression is not essential for the regulation of Armadillo PNAS, January 7, 1997; 94(1): 242 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Palmer, J. M. Gonzalez-Sancho, J. Espada, M. T. Berciano, I. Puig, J. Baulida, M. Quintanilla, A. Cano, A. G. de Herreros, M. Lafarga, et al. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of {beta}-catenin signaling J. Cell Biol., July 23, 2001; 154(2): 369 - 388. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |